Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors

References

• Thompson BJ, Ronaldson PT. Drug delivery to the ischemic brain. Adv Pharmacol 2014;71:165–202
   PubMedGoogle Scholar
• Kaur H, Prakash A, Medhi B. Drug therapy in stroke: from preclinical to clinical studies. Pharmacology 2013;92:324–34
   PubMed Web of Science ®Google Scholar
• Jahan R, Vinuela F. Treatment of acute ischemic stroke: intravenous and endovascular therapies. Expert Rev Cardiovasc Ther 2009;7:375–87
   PubMedGoogle Scholar
• Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 2004;35:e27–9
   PubMed Web of Science ®Google Scholar
• Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000;60:7075–83
   PubMed Web of Science ®Google Scholar
• Stiehl DP, Wirthner R, Köditz J, et al. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 2006;281:23482–91
   PubMed Web of Science ®Google Scholar
• Cravotto G, Balliano G, Tagliapietra S, et al. Umbelliferone aminoalkyl derivatives, a new class of squalene-hopene cyclase inhibitors. Eur J Med Chem 2004;39:917–24
   PubMed Web of Science ®Google Scholar
• Kosiova I, Kovackova S, Kois P. Synthesis of coumarin–nucleoside conjugates via Huisgen 1,3-dipolar cycloaddition. Tetrahedron 2007;63:312–20
   Web of Science ®Google Scholar
• Kwok S, Fotsing J, Fraser R, et al. Transition-metal-free catalytic synthesis of 1,5-diaryl-1,2,3-triazoles. Org Lett 2010;12:4217–19
   PubMed Web of Science ®Google Scholar
• Caddick S, Delisser VM, Doyle VE, et al. Studies toward the synthesis of natural and unnatural dienediynes 1. Approaches to a functionalised bicyclic ring system. Tetrahedron 1999;55:2737–54
   Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73
   PubMed Web of Science ®Google Scholar
• Liu F, Martin-Mingot A, Lecornué F, et al. Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry. J Enzyme Inhib Med Chem 2012;27:886–91
   PubMed Web of Science ®Google Scholar
• Ekinci D, Kurbanoglu NI, Salamci E, et al. Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds. J Enzyme Inhib Med Chem 2012;27:845–8
   PubMed Web of Science ®Google Scholar
• Hilvo M, Baranauskiene L, Salzano A, et al. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J Biol Chem 2008;283:27799–809
   PubMed Web of Science ®Google Scholar
• Nocentini A, Carta F, Ceruso M, et al. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem 2015;23:6955–66
   Google Scholar
• Casini A, Scozzafava A, Mincione F, et al. Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. J Med Chem 2000;43:4884–92
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother 2010;1:94–9
   PubMedGoogle Scholar
• Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84–91
   PubMed Web of Science ®Google Scholar
• Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995;26:627–34
   PubMed Web of Science ®Google Scholar
• Melani A, Pantoni L, Bordoni F, et al. The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res 2003;959:243–50
   PubMed Web of Science ®Google Scholar
• Bederson JB, Pitts LH, Germano SM, et al. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986;17:1304–8
   PubMed Web of Science ®Google Scholar
• Schomacher M, Müller HD, Sommer C, et al. Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res 2008;1240:213–20
   PubMed Web of Science ®Google Scholar
• Hara H, Friedlamder RM, Gagliardini V, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997;94:2007–12
   PubMed Web of Science ®Google Scholar
• Swanson RA, Sharp FR. Infarct measurement methodology. J Cereb Blood Flow Metab 1994;14:697–8
   PubMed Web of Science ®Google Scholar
• Supuran CT, Dedhar S, Carta F, et al. Carbonic anhydrase inhibitors with antimetastatic activity. WO2012070024
   Google Scholar
• Carta F, Di Cesare Mannelli L, Pinard M, et al. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. Bioorg Med Chem 2015;23:1828–40
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO(2) capture. J Enzyme Inhib Med Chem 2013;28:229–30
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72
   PubMed Web of Science ®Google Scholar
• Bonneau A, Maresca A, Winum JY. Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonicanhydrase inhibitors. J Enzyme Inhib Med Chem 2013;28:397–401
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62
   PubMed Web of Science ®Google Scholar
• Supuran CT, Ilies MA, Scozzafava A. Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives. Eur J Med Chem 1998;33:739–52
   Web of Science ®Google Scholar
• Supuran CT, Maresca A, Gregáň F, et al. Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII. J Enzyme Inhib Med Chem 2013;28:289–93
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Briganti F, Ilies MA, Supuran CT. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J Med Chem 2000;43:292–300
   PubMed Web of Science ®Google Scholar
• Matthews TA, Abel A, Demme C, et al. Expression of the CHOP-inducible carbonic anhydrase CAVI-b is required for BDNF-mediated protection from hypoxia. Brain Res 2014;1543:28–37
   PubMed Web of Science ®Google Scholar
• Agnati LF, Tinner B, Staines WA, et al. On the cellular localization and distribution of carbonic anhydrase II immunoreactivity in the rat brain. Brain Res 1995;676:10–24
   PubMed Web of Science ®Google Scholar
• Tong CK, Brion LP, Suarez C, Chesler M. Interstitial carbonic anhydrase (CA) activity in brain is attributable to membrane-bound CA type IV. J Neurosci 2000;20:8247–53
   PubMed Web of Science ®Google Scholar
• Svichar N, Esquenazi S, Waheed A, et al. Functional demonstration of surface carbonic anhydrase IV activity on rat astrocytes. Glia 2006;53:241–7
   PubMed Web of Science ®Google Scholar
• Obara M, Szeliga M, Albrecht J. Regulation of pH in the mammalian central nervous system under normal and pathological conditions: facts and hypotheses. Neurochem Int 2008;52:905–19
   PubMed Web of Science ®Google Scholar
• Diarra A, Sheldon C, Brett CL, et al. Anoxia-evoked intracellular pH and Ca2+ concentration changes in cultured postnatal rat hippocampal neurons. Neuroscience 1999;93:1003–16
   PubMed Web of Science ®Google Scholar
• Sheldon C, Diarra A, Cheng YM, Church J. Sodium influx pathways during and after anoxia in rat hippocampal neurons. J Neurosci 2004;24:11057–69
   PubMed Web of Science ®Google Scholar
• Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 2007;26:299–310
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Pettersen EO, Ebbesen P, Gieling RG, et al. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drugdevelopment: the METOXIA consortium. J Enzyme Inhib Med Chem 2015;30:689–721
   PubMed Web of Science ®Google Scholar
• Klatzo I. Brain oedema following brain ischaemia and the influence of therapy. Br J Anaesth 1985;57:18–22
   PubMed Web of Science ®Google Scholar
• Masini E, Carta F, Scozzafava A, Supuran CT. Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 2013;23:705–16
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT. Glaucoma and the applications of carbonic anhydrase inhibitors. Subcell Biochem 2014;75:349–59
   PubMedGoogle Scholar
• Jacson EK. Diuretics. In: Brunton L, Lazo J, Parker K, eds. Goodman and Giltman’s the pharmacological basis of therapeutics. 9th ed. New York: Pergamon Press Ltd; 1995;690–5
   Google Scholar
• Swenson ER. New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases. Curr Hypertens Rep 2014;16:467
   PubMed Web of Science ®Google Scholar
• Tuettenberg J, Heimann A, Kempski O. Nitric oxide modulates cerebral blood flow stimulation by acetazolamide in the rat cortex: a laser Doppler scanning study. Neurosci Lett 2001;315:65–8
   PubMed Web of Science ®Google Scholar
• Bejaoui M, Pantazi E, De Luca V, et al. Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury. J Pharmacol Exp Ther 2015;355:191–8
   PubMed Web of Science ®Google Scholar
• Kiss B, Dallinger S, Findl O, et al. Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide. Am J Physiol 1999;276:R1661–7
   PubMedGoogle Scholar
• An Y, Zhang JZ, Han J, et al. Hypoxia-inducible factor-1α dependent pathways mediate the renoprotective role of acetazolamide against renal ischemia-reperfusion injury. Cell Physiol Biochem 2013;32:1151–66
   PubMed Web of Science ®Google Scholar
• Taki K, Oogushi K, Hirahara K, et al. Preferential acetazolamide-induced vasodilation based on vessel size and organ: confirmation of peripheral vasodilation with use of colored microspheres. Angiology 2001;52:483–8
   PubMed Web of Science ®Google Scholar
• Horita Y, Yakabe K, Tadokoro M, et al. Renal circulatory effects of acetazolamide in patients with essential hypertension. Am J Hypertens 2006;19:282–5
   PubMed Web of Science ®Google Scholar
• Teppema LJ, Bijl H, Romberg RR, Dahan A. Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. J Physiol (Lond.) 2006;572:849–56
   Google Scholar
• Iida H, Nakagawara J, Hayashida K, et al. Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative spect reconstruction program and split-dose 123i-iodoamphetamine. J Nucl Med 2010;51:1624–31
   PubMed Web of Science ®Google Scholar